摘要
背景:在医学图像处理中的特征提取仍然是一个挑战,特别是在高维数据集中,其中可用样本的预期数量远远低于特征空间的维数。这在现实世界的数据中是一个常见的问题,特别是在医学图像处理中,尽管图像由数十万个体素组成,但只有少数患者可用。 目的:提取描述性和判别性特征,用维数较少的特征来表示每个样本(图像),这在维度问题的诅咒中尤为重要。 方法:本文通过数据的稀疏表示来解决这个识别问题,并通过结合专门的分类器为多模态图像(PET和MRI)数据分类提供了一个舞台。因此,这里提出了一种有效组合SVC分类器的新方法,该方法使用与每个分类器中的每个类计算的超平面的距离,从而允许在每种情况下选择最有区别的图像模态。每种方式的区别能力也提供有关疾病发展的信息。而与对照受试者(CN)相比,阿尔茨海默病患者(AD)的功能改变明显,结构改变在疾病早期似乎更为相关,影响了轻度认知功能障碍(MCI)患者。 结果:使用来自阿尔茨海默病神经影像学数据库的68 CN,70 AD和111 MCI图像进行分类实验,并通过交叉验证进行评估,以显示所提出的方法的有效性。 CN / AD和CN / MCI分类的准确度高达92%和84%。 结论:本文提出的方法表明,大脑图像的稀疏表示对于编码和传输相关图像特征具有重要意义,因为它们可以在保持轻量级数据交易的同时捕获显着特征。实际上,本文提出的方法优于使用投影方法如主成分分析提取图像代表性特征的分类结果。
关键词: 稀疏特征,多模型数据,轻度认知障碍,支持向量分类器,计算机辅助诊断,ADNI。
Current Alzheimer Research
Title:Discriminative Sparse Features for Alzheimer's Disease Diagnosis Using Multimodal Image Data
Volume: 15 Issue: 1
关键词: 稀疏特征,多模型数据,轻度认知障碍,支持向量分类器,计算机辅助诊断,ADNI。
摘要: Background: Feature extraction in medical image processing still remains a challenge, especially in high-dimensionality datasets, where the expected number of available samples is considerably lower than the dimension of the feature space. This is a common problem in real-world data, and, specifically, in medical image pro- cessing as, while images are composed of hundreds of thousands voxels, only a reduced number of patients are available.
Objective: Extracting descriptive and discriminative features to represent each sample (image) by a small number of features, which is particularly important in classification task, due to the curse of dimensionality problem.
Methods: In this paper we solve this recognition problem by means of sparse representations of the data, which also provides an arena to multimodal image (PET and MRI) data classification by combining specialized classifiers. Thus, a novel method to effectively combine SVC classifiers is presented here, which uses the distance to the hyperplane computed for each class in each classifier allowing to select the most discriminative image modality in each case. The discriminative power of each modality also provides information about the illness evolution; while functional changes are clearly found in Alzheimer’s diagnosed patients (AD) when compared to control subjects (CN), structural changes seem to be more relevant at the early stages of the illness, affecting Mild Cognitive Impairment (MCI) patients.
Results: Classification experiments using 68 CN, 70 AD and 111 MCI images from the Alzheimer's Disease Neuroimaging Initiative database have been performed and assessed by cross-validation to show the effectiveness of the proposed method. Accuracy values of up to 92% and 84% for CN/AD and CN/MCI classification are achieved.
Conclusions: The method presented in this work shows that sparse representations of brain images are of importance for codifying and transferring relevant image features, as they may capture the salient features while maintaining lightweight data transactions. In fact, the method proposed in this work outperforms the classification results obtained using projection methods such as Principal Component Analysis for extracting representative features of the images.
Export Options
About this article
Cite this article as:
Discriminative Sparse Features for Alzheimer's Disease Diagnosis Using Multimodal Image Data, Current Alzheimer Research 2018; 15 (1) . https://dx.doi.org/10.2174/1567205014666170922101135
DOI https://dx.doi.org/10.2174/1567205014666170922101135 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypersexuality As a Neuropsychiatric Disorder: The Neurobiology and Treatment Options
Current Drug Targets Comprehensive Evaluation and Clinical Application of Combined Redox Assay Methods to Determine Total Antioxidant Capacity
Current Analytical Chemistry High Throughput Optimization of Stem Cell Microenvironments
Combinatorial Chemistry & High Throughput Screening Thermodynamic and Kinetic Analyses of Nucleic Acid Structures for Pharmacogenomics
Current Pharmacogenomics Does Calprotectin Represent a Regulatory Factor in Host Defense or a Drug Target in Inflammatory Disease?
Endocrine, Metabolic & Immune Disorders - Drug Targets Genetic Enhancement in Sport: Just Another Form of Doping?
Recent Patents on DNA & Gene Sequences Curcumin Nanomedicine: A Road to Cancer Therapeutics
Current Pharmaceutical Design Editorial (Thematic Issue: The Link between Alzheimer’s Disease and Down Syndrome. A Historical Perspective)
Current Alzheimer Research Rare Germline <i>GLMN</i> Variants Identified from Blue Rubber Bleb Nevus Syndrome Might Impact mTOR Signaling
Combinatorial Chemistry & High Throughput Screening Environment and Neurodegenerative Diseases: An Update on miRNA Role
MicroRNA The prediction of response to Galantamine treatment in Patients with mild to moderate Alzheimer’s Disease
Current Alzheimer Research Therapeutic Approaches for Lysosomal Storage Diseases: A Patent Update
Recent Patents on CNS Drug Discovery (Discontinued) Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies
Current Pharmaceutical Biotechnology Liver X Receptor-Mediated Gene Regulation and Cholesterol Homeostasis in Brain: Relevance to Alzheimers Disease Therapeutics
Current Alzheimer Research Editorial: Brain Imaging and Automatic Analysis in Neurological and Psychiatric Diseases – Part I
CNS & Neurological Disorders - Drug Targets Randomized, Placebo Controlled Study of the Effects of Etoricoxib on Markers of Inflammation, Pain and Muscle Force After Eccentric Exercise
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders
Current Pharmaceutical Design Fluorinated Molecules as Drugs and Imaging Agents in the CNS
Current Topics in Medicinal Chemistry Patterns of Cognitive Impairment in Neurological Disease
Current Psychiatry Reviews Alpha-1 Antitrypsin Deficiency: Current Perspective from Genetics to Diagnosis and Therapeutic Approaches
Current Medicinal Chemistry